New Zealand markets closed

Endonovo Therapeutics, Inc. (ENDV)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0027+0.0003 (+10.20%)
At close: 11:35AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
6,925
6,925
-18,475
-3,105
-395.584
Depreciation & amortisation
646.912
646.912
646.912
648.492
651.247
Stock-based compensation
686.747
686.747
45
0
456.519
Change in working capital
1,708
1,708
1,470
1,223
1,888
Accounts receivable
-
-
0
-0.002
21.8
Accounts payable
-478.504
-478.504
-269.391
-42.47
94.202
Other working capital
121.87
121.87
-678.838
-986.584
-741.59
Other non-cash items
1,178
1,178
1,969
310.416
1,710
Net cash provided by operating activities
121.87
121.87
-678.838
-986.584
-741.59
Cash flows from investing activities
Net cash used for investing activities
-
-
-
0
0
Cash flows from financing activities
Debt repayment
-121.05
-121.05
-
-
0
Common stock issued
10.72
10.72
142
126
100
Other financing activities
-9.8
-9.8
-14
-16.9
-22
Net cash used provided by (used for) financing activities
-120.13
-120.13
593
1,059
736.117
Net change in cash
1.74
1.74
-85.838
72.516
-5.473
Cash at beginning of period
0.098
0.098
85.936
13.42
18.893
Cash at end of period
1.838
1.838
0.098
85.936
13.42
Free cash flow
Operating cash flow
121.87
121.87
-678.838
-986.584
-741.59
Free cash flow
121.87
121.87
-678.838
-986.584
-741.59